Phibro Animal Health (PAHC) Competitors $18.78 +0.17 (+0.91%) As of 03:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAHC vs. VKTX, XENE, MLTX, ALVO, IMVT, HCM, ACAD, APLS, AMRX, and RXRXShould you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Viking Therapeutics (VKTX), Xenon Pharmaceuticals (XENE), MoonLake Immunotherapeutics (MLTX), Alvotech (ALVO), Immunovant (IMVT), HUTCHMED (HCM), ACADIA Pharmaceuticals (ACAD), Apellis Pharmaceuticals (APLS), Amneal Pharmaceuticals (AMRX), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "pharmaceutical products" industry. Phibro Animal Health vs. Viking Therapeutics Xenon Pharmaceuticals MoonLake Immunotherapeutics Alvotech Immunovant HUTCHMED ACADIA Pharmaceuticals Apellis Pharmaceuticals Amneal Pharmaceuticals Recursion Pharmaceuticals Phibro Animal Health (NASDAQ:PAHC) and Viking Therapeutics (NASDAQ:VKTX) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, risk, profitability, analyst recommendations, dividends, media sentiment and valuation. Does the MarketBeat Community prefer PAHC or VKTX? Viking Therapeutics received 319 more outperform votes than Phibro Animal Health when rated by MarketBeat users. Likewise, 80.08% of users gave Viking Therapeutics an outperform vote while only 59.85% of users gave Phibro Animal Health an outperform vote. CompanyUnderperformOutperformPhibro Animal HealthOutperform Votes31659.85% Underperform Votes21240.15% Viking TherapeuticsOutperform Votes63580.08% Underperform Votes15819.92% Do institutionals & insiders have more ownership in PAHC or VKTX? 99.3% of Phibro Animal Health shares are owned by institutional investors. Comparatively, 76.0% of Viking Therapeutics shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by insiders. Comparatively, 4.1% of Viking Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is PAHC or VKTX more profitable? Phibro Animal Health has a net margin of 1.75% compared to Viking Therapeutics' net margin of 0.00%. Phibro Animal Health's return on equity of 25.35% beat Viking Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health1.75% 25.35% 6.21% Viking Therapeutics N/A -11.93%-11.57% Which has more risk & volatility, PAHC or VKTX? Phibro Animal Health has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, Viking Therapeutics has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Does the media favor PAHC or VKTX? In the previous week, Viking Therapeutics had 55 more articles in the media than Phibro Animal Health. MarketBeat recorded 58 mentions for Viking Therapeutics and 3 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.13 beat Viking Therapeutics' score of 0.15 indicating that Phibro Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Viking Therapeutics 14 Very Positive mention(s) 8 Positive mention(s) 8 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral Which has better valuation and earnings, PAHC or VKTX? Phibro Animal Health has higher revenue and earnings than Viking Therapeutics. Viking Therapeutics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.11B0.68$2.42M$0.4838.74Viking TherapeuticsN/AN/A-$109.96M-$1.15-24.67 Do analysts recommend PAHC or VKTX? Phibro Animal Health presently has a consensus price target of $19.75, suggesting a potential upside of 6.21%. Viking Therapeutics has a consensus price target of $87.15, suggesting a potential upside of 207.14%. Given Viking Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Viking Therapeutics is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Viking Therapeutics 0 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 3.00 SummaryPhibro Animal Health beats Viking Therapeutics on 10 of the 18 factors compared between the two stocks. Get Phibro Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAHC vs. The Competition Export to ExcelMetricPhibro Animal HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$753.15M$6.72B$5.49B$7.97BDividend Yield2.67%3.05%5.11%4.23%P/E Ratio38.747.3622.6118.58Price / Sales0.68241.71397.51103.15Price / Cash10.8765.8538.1834.62Price / Book3.056.486.704.26Net Income$2.42M$143.43M$3.22B$248.31M7 Day Performance3.19%1.69%1.26%1.34%1 Month Performance-15.36%6.58%3.73%3.92%1 Year Performance13.73%-2.63%15.82%5.33% Phibro Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAHCPhibro Animal Health3.3414 of 5 stars$18.78+0.9%$19.75+5.2%+11.4%$760.65M$1.11B39.131,860Upcoming EarningsPositive NewsVKTXViking Therapeutics4.4972 of 5 stars$23.72-0.9%$89.75+278.4%-63.7%$2.66BN/A-23.7220Analyst ForecastOptions VolumeAnalyst RevisionXENEXenon Pharmaceuticals2.5911 of 5 stars$34.70-1.2%$56.78+63.6%-6.0%$2.66B$9.43M-12.30210Upcoming EarningsOptions VolumePositive NewsMLTXMoonLake Immunotherapeutics1.5529 of 5 stars$40.00+4.4%$80.50+101.3%+2.9%$2.56BN/A-31.012Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsALVOAlvotech1.7401 of 5 stars$8.33+0.5%$18.00+116.1%-45.9%$2.51B$489.68M-4.504Short Interest ↑IMVTImmunovant2.2237 of 5 stars$14.46-4.6%$41.00+183.5%-41.1%$2.46BN/A-5.52120High Trading VolumeHCMHUTCHMED1.9657 of 5 stars$13.89+0.9%$19.00+36.8%-19.8%$2.42B$630.20M0.001,760Short Interest ↑ACADACADIA Pharmaceuticals4.2586 of 5 stars$14.38-2.4%$23.93+66.4%-12.6%$2.40B$957.80M18.44510Upcoming EarningsAnalyst ForecastPositive NewsAPLSApellis Pharmaceuticals4.1182 of 5 stars$18.03-0.9%$45.35+151.5%-56.5%$2.26B$781.37M-8.88770Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageAMRXAmneal Pharmaceuticals3.347 of 5 stars$7.13-3.1%$10.80+51.5%+26.6%$2.21B$2.79B-10.497,600News CoveragePositive NewsRXRXRecursion Pharmaceuticals2.2167 of 5 stars$5.41-1.6%$8.20+51.6%-28.5%$2.17B$58.49M-3.54400Upcoming Earnings Related Companies and Tools Related Companies VKTX Competitors XENE Competitors MLTX Competitors ALVO Competitors IMVT Competitors HCM Competitors ACAD Competitors APLS Competitors AMRX Competitors RXRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAHC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAHC Stock Free PAHC Stock Alerts